Peripheral blood progenitor cell collections in cancer patients: Analysis of factors affecting the yields

Haematologica

Volumn 84, Issue 4, 1999, Pages 342-349

  Sautois, Brieuc ^b   Fraipont, Vincent ^b   Baudoux, Etienne ^a   Fassotte, Marie France ^b   Hermanne, Jean Philippe ^b   Jérusalem, Guy ^b   Bours, Vincent ^b   Bosquée, Lionel ^b   Schaaf Lafontaine, Nicole ^b   Paulus, Jean Michel ^b   Sondag, Danielle ^a   Fillet, Georges ^b   Beguin, Yves ^c  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b CHR Citadelle ^*

^c CHU SART TILMAN   (Belgium)

Author keywords

CD34 antigen; Hematopoietic progenitors; Hematopoietic stem cell transplantation; PBPC collections

Indexed keywords

CD34 ANTIGEN; GRANULOCYTE COLONY STIMULATING FACTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD SAMPLING; BREAST CANCER; CANCER PATIENT; CHILD; COLONY FORMING UNIT GM; CONTROLLED STUDY; FEMALE; HEMATOPOIESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKAPHERESIS; LEUKOCYTE COUNT; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MOBILIZATION; SOLID TUMOR; STEM CELL;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD34; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLOOD CELL COUNT; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKAPHERESIS; MALE; MIDDLE AGED; NEOPLASMS; PREDICTIVE VALUE OF TESTS; TRANSPLANTATION, AUTOLOGOUS;

EID: 0032846113     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Beyer J, Schwella N, Zingsem J, et al. Hematopoietic rescue after high-dose chemotherapy using autologous peripheral-blood progenitor cells or bone marrow: a randomized comparison. J Clin Oncol 1995; 13:1328-35.
2. Schmitz N, Linch DC, Dreger P, et al. Randomised trial of filgastrim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients. Lancet 1996; 347:353-7.
3. Faucher C, le Corroder AG, Blaise D, et al. Comparison of G-CSF-primed peripheral blood progenitor cells and bone marrow auto transplantation: clinical assessment and cost-effectiveness. Bone Marrow Transplant 1994; 14:895-901.
4. Brugger W, Birken R, Bertz H, et al. Peripheral blood progenitor cells mobilized by chemotherapy plus granulocyte colony-stimulating factor accelerate both neutrophil and platelet recovery after high-dose VP16, ifosfamide and cisplatin. Br J Haematol 1993; 84:402-7.
5. Ager S, Scott MA, Mahendra P, et al. Peripheral blood stem cell transplantation after high-dose therapy in patients with malignant lymphoma: a retrospective comparison with autologous bone marrow transplantation. Bone Marrow Transplant 1995; 16:79-83.
6. Dreger P, Kloss M, Petersen B, et al. Autologous progenitor cell transplantation: prior exposure to stem cell-toxic drugs determines yield and engraftment of peripheral blood progenitor cell but not of bone marrow grafts. Blood 1995; 86:3970-8.
7. Sheridan WP, Begley CG, Juttner CA, et al. Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet 1992; 339:640-4.
8. To LB, Roberts MM, Haylock DN, et al. Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants. Bone Marrow Transplant 1992; 9:277-84.
9. Peters WP, Rosner G, Ross M, et al. Comparative effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy. Blood 1993; 81:1709-19.
10. Gianni AM, Siena S, Bregni M, et al. Granulocyte-macrophage colony-stimulating factor to harvest circulating haemopoietic stern cells for autotransplantation. Lancet 1989; 2:580-5.
11. Ho AD, Gluck S, Germond C, et al. Optimal timing for collections of blood progenitor cells following induction chemotherapy and granulocyte-macrophage colony-stimulating factor for autologous transplantation in advanced breast cancer. Leukemia 1993; 7: 1738-46.
12. Kotasek D, Shepherd KM, Sage RE, et al. Factors affecting blood stem cell collections following high-dose cyclophosphamide mobilization in lymphoma, myeloma and solid tumors. Bone MarrowTransplant 1992; 9:11-7.
13. Emminger W, Emminger Schmidmeier W, et al. The median daily increment of leukocytes during hematopoietic recovery reflects the myeloid progenitor cell yield during leukapheresis in children. Bone Marrow Transplant 1990; 5:419-24.
14. Bensinger WI, Longin K, Appelbaum F, et al. Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony-stimulating factor (rhG-CSF): an analysis of factors correlating with the tempo of engraftment after transplantation. Br J Haematol 1994; 87:825-31.
15. Tricot G, Jagannath S, Vesole D, et al. Peripheral blood stem cell transplants for multiple myeloma: identification of favorable variables for rapid engraftment in 225 patients. Blood 1995; 85:588-96.
16. Weaver CH, Hazelton B, Birch R, et al. An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy. Blood 1995; 86:3961-9.
17. Hohaus S, Goldschmidt H, Ehrhardt R, Haas R. Successful autografting following myeloablative conditioning therapy with blood stem cells mobilized by chemotherapy plus rhG-CSF. Exp Hematol 1993; 21:508-14.
18. Zimmerman TM, Lee WJ, Bender JG, Mick R, Williams SF. Quantitative CD34 analysis may be used to guide peripheral blood stem cell harvests. Bone Marrow Transplant 1995; 15:439-44.
19. Passos Coelho JL, Braine HG, Davis JM, et al. Predictive factors for peripheral-blood progenitor-cell collections using a single large-volume leukapheresis after cyclophosphamide and granulocyte-macrophage colony-stimulating factor mobilization. J Clin Oncol 1995; 13:705-14.
20. Schneider JG, Crown JP, Wasserheit C, et al. Factors affecting the mobilization of primitive and committed hematopoietic progenitors into the peripheral blood of cancer patients. Bone Marrow Transplant 1994; 14:877-84.
21. BenderJG, Lum L, Unverzagt KL, et al. Correlation of colony-forming cells, long-term culture initiating cells and CD34+ cells in apheresis products from patients mobilized for peripheral blood progenitors with different regimens. Bone Marrow Transplant 1994; 13: 479-85.
22. Fruehauf S, Haas R, Conradt C, et al. Peripheral blood progenitor cell (PBPC) counts during steady-state hematopoiesis allow to estimate the yield of mobilized PBPC after filgrastim (R-metHuG-CSF)-supported cytotoxic chemotherapy. Blood 1995; 85:2619-26.
23. Siena S, Bregni M, Brando B, et al. Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood 1991; 77:400-9.
24. Schwartzberg LS, Birch R, Hazelton B, et al. Peripheral blood stem cell mobilization by chemotherapy with and without recombinant human granulocyte colony-stimulating factor. J Hematother 1992; 1:317-27.
25. Papadopoulos KP, Ayello J, Tugulea S, et al. Harvest quality and factors affecting collection and engraftment of CD34+ cells in patients with breast cancer scheduled for high-dose chemotherapy and peripheral blood progenitor cell support .J Hematother 1997; 6:61-8.
26. Pettengell R, Morgenstern GR, Woll PJ, et al. Peripheral blood progenitor cell transplantation in lymphoma and leukemia using a single apheresis. Blood 1993; 82:3770-7.
27. Olivieri A, Offidani M, Ciniero L, et al. Optimization of the yield of PBSC for autotransplantation mobilized by high-dose chemotherapy and G-CSF: proposal for a mathematical model. Bone Marrow Transplant 1994; 14:273-8.
28. Bensinger W, Appelbaum F, Rowley S, et al. Factors that influence collection and engraftment of autologous peripheral-blood stem cells. J Clin Oncol 1995; 13:2547-55.
29. McQuaker IG, Haynes AP, Stainer C, Anderson S, Russell NH. Stem cell mobilization in resistant or relapsed lymphoma: superior yield of progenitor cells following a salvage regimen comprising ifosfamide, etoposide and epirubicin compared to intermediate-dose cyclophosphamide. Br J Haematol 1997; 98:228-33.
30. Olivieri A, Offidani M, Ciniero L, et al. PBSC collection after high dose chemotherapy followed by G-CSF in patients with malignancies: analysis of results regarding factors affecting the yield of hemopoietic progenitors. Int J Artif Organs 1993; 16 (Suppl 5):57-63.
31. Sutherland HJ, Eaves CJ, Lansdorp PM, Phillips GL, Hogge DE. Kinetics of committed and primitive blood progenitor mobilization after chemotherapy and growth factor treatment and their use in autotransplants. Blood 1994; 83:3808-14.
32. Teshima T, Harada M, Takamatsu Y, et al. Granulocyte colony-stimulating factor(G-CSF)-induced mobilization of circulating haemopoietic stem cells. Br J Haematol 1993; 84:570-3.
33. Verbik DJ, Jackson JD, Pirruccello SJ, Patil KD, Kessinger A, Joshi SS. Functional and phenotypic characterization of human peripheral blood stem cell harvests: a comparative analysis of cells from consecutive collections. Blood 1995; 85:1964-70.
34. Gazitt Y, Tian E, Barlogie B, et al. Differential mobilization of myeloma cells and normal hematopoietic stem cells in multiple myeloma after treatment with cyclophosphamide and granulocyte-macrophage colony-stimulating factor. Blood 1996; 87:805-11.
35. Brugger W, Bross KJ, Glatt M, Weber F, Mertelsmann R, Kanz L. Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors. Blood 1994; 83:636-40.
36. Chapple P, Prince H, Quinn M, et al. Peripheral blood CD34+ cell count reliably predicts autograft yield. Bone Marrow Transplant 1998; 22:125-30.
37. Elliott C, Samson DM, Armitage S, et al. When to harvest peripheral-blood stem cells after mobilization therapy: prediction of CD34-positive cell yield by preceding day CD34-positive concentration in peripheral blood. J Clin Oncol 1996; 14:970-3.
38. Armitage S, Hargreaves R, Samson D, Brennan M, Kanfer E, Navarrete C. CD34 counts to predict the adequate collection of peripheral blood progenitor cells. Bone Marrow Transplant 1997; 20:587-91.
39. Haas R, Mohle R, Fruhauf S, et al. Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood 1994; 83:3787-94.
40. Watanabe S, Mukaiyama T, Ogawa Y, Kawada H, Ichikawa Y. Peripheral blood stem cell mobilization with chemotherapy and granulocyte colony-stimulating factor in patients with hematological malignancies. Tokai J Exp Clin Med 1994; 19:143-55.
41. Craig JI, Anthony RS, Stewart A, Thomson EB, Gillon J, Parker AC. Peripheral blood stem cell mobilization using high-dose cyclophosphamide and G-CSF in pretreated patients with lymphoma. Br J Haematol 1993; 85:210-2.
42. Olivieri A, Offidani M, Montanari M, et al. Factors affecting hemopoietic recovery after high-dose therapy and autologous peripheral blood progenitor cell transplantation: a single center experience. Haematologica 1998; 83:329-37.
43. Sampol Mayol A, Besalduch Vital J, Galmes Llodra A, et al. CD34+ cell dose and CD33-subsets: collection and engraftment kinetics in autologous peripheral blood stem cells transplantation. Haematologica 1998; 83:489-95.